Cargando…

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure

Detalles Bibliográficos
Autores principales:	Farsad, Khashayar, Nabavizadeh, Nima, Kardosh, Adel, Jou, Janice H., Naugler, Willscott E., Kolbeck, Kenneth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812172/ https://www.ncbi.nlm.nih.gov/pubmed/33490212 http://dx.doi.org/10.21037/atm-20-4164

Ejemplares similares

Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?
por: Tholey, Danielle M, et al.
Publicado: (2017)

Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma
por: Koh, Sukjin, et al.
Publicado: (2018)

Bile Acid Flux Is Necessary for Normal Liver Regeneration
por: Naugler, Willscott E.
Publicado: (2014)

Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations
por: Patel, Ranish K., et al.
Publicado: (2023)

Baseline Tumor Lipiodol Uptake after Transarterial Chemoembolization for Hepatocellular Carcinoma: Identification of a Threshold Value Predicting Tumor Recurrence
por: Matsui, Yusuke, et al.
Publicado: (2017)

Obscure Gastrointestinal Bleeding: Capsule or Balloon?
por: Lee, Bo-In
Publicado: (2016)

Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
por: Makary, Mina S, et al.
Publicado: (2021)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
por: Inchingolo, Riccardo, et al.
Publicado: (2019)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies
por: Roskams-Hieter, Breeshey, et al.
Publicado: (2022)

What is the Role of Double-Balloon Endoscopy in Patients Presenting with Obscure Gastrointestinal Bleeding?
por: Kim, Jung Ho, et al.
Publicado: (2017)

Portal Biliopathy Causing Recurrent Biliary Obstruction and Hemobilia
por: Schlansky, Barry, et al.
Publicado: (2013)

Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
por: Garneau, Alexandre P., et al.
Publicado: (2022)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future
por: Woo, Hyun Young, et al.
Publicado: (2020)

Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions
por: Choksi, Eshani J., et al.
Publicado: (2023)

Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice
por: Celsa, Ciro, et al.
Publicado: (2023)

Paenibacillus larvae bacteriophages: obscure past, promising future
por: Tsourkas, Philippos K.
Publicado: (2020)

Comments on "Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients"
por: Sindoni, Alessandro, et al.
Publicado: (2016)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?
por: Martins, Noel B., et al.
Publicado: (2017)

Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
por: Huber, Timothy C, et al.
Publicado: (2021)

Jude the obscure
por: Hardy, Thomas, 1840-1928
Publicado: (1961)

Jude the obscure /
por: Hardy, Thomas, 1840-1928
Publicado: (1959)

Obscured by clouds
Publicado: (1988)

Obscurity on Obesity
por: Winkler, Jack
Publicado: (2014)

Obscure Case
por: Scott, H.
Publicado: (1872)

An Obscure Case
Publicado: (1877)

An Obscure Case
por: Walker, W. E.
Publicado: (1897)

An Obscure Case
por: Clement, A. W.
Publicado: (1895)

Commentary: Mesothelioma … moving the needle on locoregional control has invited aggressive treatment options for limited distant metastases
por: Lanuti, Michael
Publicado: (2020)

DeGowin's Diagnostic Examination, 7th Edition
por: Farsad, Khashayar
Publicado: (2001)

Neuroanatomy: An Atlas of Structures, Sections, and Systems, 5th Edition
por: Farsad, Khashayar
Publicado: (2001)

Exosomes: novel organelles implicated in immunomodulation and apoptosis.
por: Farsad, Khashayar
Publicado: (2002)

Handbook of Neurosurgery, Fifth Edition
por: Farsad, Khashayar
Publicado: (2001)

Medicine for the Outdoors: The Essential Guide to Emergency Medical Procedures and First Aid
por: Farsad, Khashayar
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_dheuo45e4bc9vehmtn95623794